摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-chloro-6-formyl-1,3-dimethyl-8-phenyl-pyrido<2,3-d>pyrimidine-2,4,7(1H,3H,8H)-trione | 177082-57-4

中文名称
——
中文别名
——
英文名称
5-chloro-6-formyl-1,3-dimethyl-8-phenyl-pyrido<2,3-d>pyrimidine-2,4,7(1H,3H,8H)-trione
英文别名
5-Chloro-1,3-dimethyl-2,4,7-trioxo-8-phenylpyrido[2,3-d]pyrimidine-6-carbaldehyde
5-chloro-6-formyl-1,3-dimethyl-8-phenyl-pyrido<2,3-d>pyrimidine-2,4,7(1H,3H,8H)-trione化学式
CAS
177082-57-4
化学式
C16H12ClN3O4
mdl
——
分子量
345.742
InChiKey
KKWLJZVIKAJWGM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    404.8±55.0 °C(Predicted)
  • 密度:
    1.56±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    24
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    78
  • 氢给体数:
    0
  • 氢受体数:
    4

SDS

SDS:905822c1d1189dccf2709586910b98ca
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2

反应信息

  • 作为反应物:
    描述:
    5-chloro-6-formyl-1,3-dimethyl-8-phenyl-pyrido<2,3-d>pyrimidine-2,4,7(1H,3H,8H)-trione 在 sodium azide 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 2.0h, 以85%的产率得到5-azido-1,3-dimethyl-2,4,7-trioxo-8-phenyl-1,2,3,4,7,8-hexahydropyrido[2,3-d]pyrimidine-6-carbaldehyde
    参考文献:
    名称:
    5- azidopyrido [2,3的环闭合反应d ] pyrimidinetriones到isoxazolo-和oxadiazolopyrido [2,3- d ] pyrimidinetriones †
    摘要:
    具有反应性邻位取代基(如甲酰基或硝基)的5-叠氮基吡啶并[2,3 - d ]嘧啶2和7的热分解生成异恶唑并[3',4':4,5]吡啶并[2,3- d ]嘧啶3或恶二唑-[3',4':4,5]吡啶[2,3- d ]嘧啶9.通过差示扫描量热法(DSC)研究了叠氮化物分解的反应条件。另外,研究了将N-氧化物9脱氧为恶二唑10和将叠氮化物7区域选择性还原为胺8。
    DOI:
    10.1002/jhet.5570450621
  • 作为产物:
    参考文献:
    名称:
    Ring closure reaction of 5-hydroxy-pyrido[2,3-d]pyrimidine-2,4,7-triones to benzo[b]pyrimido[4,5-h]1,6-naphthyridine-1,3,6-triones
    摘要:
    N-Substituted aminouracils (1) react with malonates by cyclocondensation to 5-hydroxy-pyrido [2,3-d] pyrimidine-2,4,7-triones (2), which give with triethylorthoformate and aniline 6-(phenylaminomethylene)-pyrido[2,3-d]pyrimidine-tetraone (3). Halogenation of 2a-d (with R(2) = Me) with phosphorylchloride leads to 5,7-dichloro-pyrido [2,3-d]pyrimidine-2,4-diones (4) by cleavage of the methyl group at N-8, whereas Vilsmeier reaction of 2 affords 5-chloro-6-formyl derivatives (6), which cyclize with arylamines to give benzo[b]pyrimido[4,5-h] 1,6-naphthyridines (9). Compounds 9 were obtained independently by amination of the tosylates 5 to the 5-arylamino compounds 8, and Vilsmeier formylation to yield 9.
    DOI:
    10.1002/prac.19963380129
点击查看最新优质反应信息

文献信息

  • Synthesis of 5-mono- and 5,7-diamino-pyrido[2,3-<i>d</i>]-pyrimidinediones with potential biological activity by regioselective amination
    作者:Dang Van Tinh、Wolfgang Stadlbauer
    DOI:10.1002/jhet.5570450329
    日期:2008.5
    triphenyl-phosphane via Staudinger reaction. Hydrolysis with aqueous acetic acid produced in one step 7-unsubstituted-amino-pyrido[2,3-d]pyrimidine-2,4-diones 12. In a similar amination reaction, 5-chloropyrido[2,3-d]pyrimidine-2,4,7-triones 13 were aminated and formylated to 5-alkyl/arylamino-6-formyl derivatives 14-16 in a combined one-step-reaction with bulky arylamines or alkylamines in the presence of dimethylformamide
    由相应的5,7-二氯制备5-烷基-/芳基氨基-和5,7-二烷基/芳基氨基-吡啶并[2,3- d ]嘧啶-2,4-二酮(4,5,7-9)。在区域选择性反应中与脂肪族和芳香族胺3和6一起合成-pyrido [2,3- d ] pyrimidine-2,4-diones 2。通过5-氨基-7-氯衍生物4的叠氮化而获得的7-单叠氮化物10通过Staudinger反应与三苯基膦反应而转化为亚氨基正膦。用一步法制得的乙酸水溶液水解7-未取代的氨基-吡啶并[2,3 - d ]嘧啶-2,4-二酮12。以类似的胺化反应中,5-氯吡啶并[2,3- d ]嘧啶-2,4,7-三酮13进行胺化和甲酰化,5-烷基/芳基氨基-6-甲酰基衍生物14 - 16在组合的单步-在二甲基甲酰胺的存在下与庞大的芳胺或烷基胺的反应。
  • Bi-functional complexes and methods for making and using such complexes
    申请人:Gouliaev Alex Haahr
    公开号:US11225655B2
    公开(公告)日:2022-01-18
    The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.
    本发明涉及一种合成双功能复合物的方法,该复合物包括分子部分和识别分子部分的识别寡核苷酸部分。根据本发明的合成方法的一部分优选在一种或多种有机溶剂中进行,此时包含可选保护标签或寡核苷酸标识符的新生双功能复合物与固体支持物相连接,合成方法的另一部分优选在适合于将寡核苷酸标签酶加到溶液中的新生双功能复合物的条件下进行。
  • BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
    申请人:Nuevolution A/S
    公开号:EP2558577A1
    公开(公告)日:2013-02-20
  • BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES
    申请人:Gouliaev Alex Haahr
    公开号:US20130281324A1
    公开(公告)日:2013-10-24
    The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.
  • [EN] BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES<br/>[FR] COMPLEXES BIFONCTIONNELS ET PROCÉDÉS DE FABRICATION ET D'UTILISATION DE TELS COMPLEXES
    申请人:NUEVOLUTION AS
    公开号:WO2011127933A1
    公开(公告)日:2011-10-20
    The present invention is directed to a method for the synthesis of a bi-functional complex comprising a molecule part and an identifier oligonucleotide part identifying the molecule part. A part of the synthesis method according to the present invention is preferably conducted in one or more organic solvents when a nascent bi-functional complex comprising an optionally protected tag or oligonucleotide identifier is linked to a solid support, and another part of the synthesis method is preferably conducted under conditions suitable for enzymatic addition of an oligonucleotide tag to a nascent bi-functional complex in solution.
查看更多

同类化合物

阿昔替酯 螺喹唑啉 苯并[g][1,2,3]三唑并[4',5':5,6]吡啶并[2,1-b]喹唑啉-13(2H)-酮 脱氢利培酮 盐酸曲林菌素 甲硫利马唑 甲基8-乙基-2-甲氧基-5-氧代-5,8-二氢吡啶并[2,3-d]嘧啶-6-羧酸酯 甲基8-乙基-2-(甲硫基)-5-氧代-5,6,7,8-四氢吡啶并[2,3-d]嘧啶-6-羧酸酯 甲基2-乙氧基-8-乙基-5-氧代-吡啶并[6,5-d]嘧啶-6-羧酸酯 溴他替尼 泮托拉唑杂质DF 氨甲酸,[(2R,3E)-2-羟基-3-戊烯基]-,1,1-二甲基乙基酯(9CI) 柱孢藻毒素 曲美替尼 曲美替尼 曲喹辛 帕潘立酮棕榈酸酯 帕潘立酮杂质7 帕潘立酮杂质 帕潘立酮杂质 帕潘立酮 帕泊昔布杂质117 帕利哌酮十四酸酯 帕利哌酮N-氧化物 布喹特林 巴马斯汀 奥卡哌酮 多夸司特 吡曲克辛 吡嘧司特钾 吡嘧司特 吡啶并[4,3-d]嘧啶-4(1H)-酮,4,5,6,7-四氢-6-甲基-2-苯基- 吡啶并[4,3-D]嘧啶-2,4(1H,3H)-二酮 吡啶并[3,4-D]嘧啶-2,4(1H,3H)-二酮 吡啶并[3,2-d]嘧啶-4(3H)-酮,3-甲基-2-(甲基氨基)- 吡啶并[3,2-d]嘧啶-4(3H)-酮 吡啶并[3,2-d]嘧啶-4(1H)-酮,2,3-二氢-3-(2-羟基苯基)-2-硫代- 吡啶并[3,2-d]嘧啶-2,4(1H,3H)-二酮 吡啶并[2,3-d]嘧啶-7(8h)-酮,2,6-二溴-8-环戊基-5-甲基- 吡啶并[2,3-d]嘧啶-7(8H)-酮 吡啶并[2,3-d]嘧啶-7(1H)-酮,4-氨基-5,6-二氢-5-甲基- 吡啶并[2,3-d]嘧啶-6-羧酸,1-(2,4-二甲基苯基)-1,4-二氢-2,7-二甲基-4-羰基-,酰肼 吡啶并[2,3-d]嘧啶-4(3H)-酮,5,7-二甲基-2-(甲硫基)-3-苯基- 吡啶并[2,3-d]嘧啶-4(3H)-酮 吡啶并[2,3-d]嘧啶-4(1H)-酮,2,3-二氢-1-(4-甲基苯基)-2-硫代- 吡啶并[2,3-d]嘧啶-2-胺 吡啶并[2,3-d]嘧啶 吡啶并[2,3-D]嘧啶-4-胺 吡啶并[2,3-D]嘧啶-2,4,7(1H,3H,8H)-三酮 吡啶并[2,3-D]嘧啶-2,4(1H,3H)-二酮